GLP-1 receptor agonists are a class of therapeutic agents, including both synthetic peptides and small molecules, that mimic the action of glucagon-like peptide-1, an incretin hormone essential for maintaining… Read more









GLP-1 receptor agonists are a class of therapeutic agents, including both synthetic peptides and small molecules, that mimic the action of glucagon-like peptide-1, an incretin hormone essential for maintaining glucose homeostasis. Primarily utilized in the treatment of type 2 diabetes and increasingly for obesity management, these compounds function by stimulating insulin secretion while inhibiting glucagon release. Laboratories involved in pharmaceutical development use this selection of GLP-1 receptor agonists to facilitate rigorous analytical testing and quality control processes. This category provides essential reference standards, including stable isotope labelled compounds and related impurity profiles, which are critical for method validation and ensuring regulatory compliance. By offering high-quality analytical materials, these tools enable precise identification and quantification of degradation products and metabolites throughout the drug development lifecycle, supporting the synthesis and characterization of safe, efficacious therapeutic agents.